Related Experiment Video

Updated: Jul 8, 2026

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
13:09

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol

Published on: April 1, 2018

Cognition assessment in paediatric clinical trials

Chris J Edgar1, Keith A Wesnes

  • 1Cognitive Drug Research Ltd., CDR House, Goring-on-Thames, UK. chris@cognitionstudy.com

Drug Discovery Today
|January 15, 2008
PubMed

Insights

Cognitive dysfunction in children requires careful assessment, especially when using medications. New regulations necessitate reliable cognitive tests for pediatric clinical trials to ensure patient safety and development.

Area of Science:

  • Pediatric clinical pharmacology
  • Neuroscience
  • Developmental psychology

Background:

  • Paediatric conditions can cause cognitive dysfunction.
  • Medications used in children may adversely affect cognition.
  • Cognitive development in children is a critical area of concern.

Purpose of the Study:

  • To highlight the importance of cognitive assessments in pediatric populations.
  • To address the need for validated cognitive assessment methods in pediatric clinical trials.
  • To emphasize the relevance of evaluating cognitive effects of medications in children.

Main Methods:

  • Review of existing literature on pediatric cognitive dysfunction.
  • Analysis of the impact of medicinal products on pediatric cognition.
  • Examination of regulatory requirements for pediatric clinical trials.

Main Results:

  • Cognitive dysfunction is prevalent in pediatric conditions.
  • Adverse cognitive effects from medications are a significant concern in children.
  • Existing cognitive assessment methods may not be adequate for pediatric trials.

Conclusions:

  • Cognitive assessments are crucial in pediatric clinical trials.
  • There is an increased demand for validated cognitive assessment tools for children and adolescents.
  • Ensuring cognitive safety and development is paramount in pediatric drug evaluation.

More Related Videos

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

An Electrophysiology Protocol to Measure Reward Anticipation and Processing in Children05:04

An Electrophysiology Protocol to Measure Reward Anticipation and Processing in Children

Published on: October 4, 2018

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...